Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

RIGL stock hub

Rigel Pharmaceuticals, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

RIGLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

481.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

RIGL

In the news

Latest news · RIGL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E6.8

P25 12.3P50 18.4P75 33.1

Trailing P/E1.4

P25 14.9P50 23.2P75 38.5

ROE174.1

P25 -105.6P50 -46.5P75 -3.1

ROIC42.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All RIGL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

248

Groups with data

Currency

USD

Showing 248 of 248 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001034842
Company name	Rigel Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	766559702
Employees	174
Employees Change	10%
Employees Change Percent	6.1
Enterprise value	$380.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2000-11-29
Isin	US7665597024
Last refreshed	2026-05-10
Market cap	$481.8M
Market cap category	Small-Cap
Price	$26.04
Price currency	USD
Rev Per Employee	1,722,798.85x
Sector	Healthcare
Sic	2834
Symbol	RIGL
Website	https://www.rigel.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	75.6%
EV Earnings	1.05x
EV Sales Forward	1.29x
EV/EBIT	3.06x
EV/EBITDA	3x
EV/FCF	4.8x
EV/Sales	1.27x
FCF yield	16.45%
Forward P/E	6.81x
P/B ratio	1.2x
P/E ratio	1.37x
P/S ratio	1.61x
PS Forward	1.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	41.56%
EBITDA Margin	42.36%
FCF margin	26.44%
Gross margin	81.2%
Gross Profit	$243.4M
Gross Profit Growth	55.78%
Gross Profit Growth Q	5.06%
Gross Profit Growth3 Y	53.28%
Gross Profit Growth5 Y	28.66%
Net Income	$364.2M
Net Income Growth	879.7%
Net Income Growth Q	-24.39%
Net Income Growth Years	3%
Pretax Margin	40.69%
Profit Margin	121.51%
Profit Per Employee	$2.1M
Profitable Years	2
ROA	22.88
Roa5y	-1.88
ROCE	30.01
ROE	174.1
ROIC	42.32
Roic5y	-236.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.21%
Cagr15y	-7.22%
Cagr1y	41.02%
Cagr20y	-6.78%
Cagr3y	30.19%
Cagr5y	-5.08%
EPS Growth	809.5
EPS Growth Q	-30.16
EPS Growth Years	3
FCF Growth	122.96%
OCF Growth	122.73%
Revenue Growth	47.61x
Revenue Growth Q	10.28x
Revenue Growth Quarters	9x
Revenue Growth Years	2x
Revenue Growth3 Y	33.82x
Revenue Growth5 Y	18.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.88
Assets	$504.6M
Cash	$146.7M
Current Assets	$234M
Current Liabilities	$89.5M
Debt	$45.7M
Debt EBITDA	$0.36
Debt Equity	$0.11
Debt FCF	$0.58
Equity	$399.9M
Interest Coverage	18.05
Liabilities	$104.7M
Long Term Assets	$270.6M
Long Term Liabilities	$15.2M
Net Cash	$101M
Net Cash By Market Cap	$20.96
Net Debt EBITDA	$-0.8
Net Debt Equity	$-0.25
Net Debt FCF	$-1.27
Tangible Book Value	$375.7M
Tangible Book Value Per Share	$20.33
WACC	10.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.62
Inventory Turnover	2.72
Net Working Capital	$28.4M
Quick ratio	2.2
Working Capital	$144.5M
Working Capital Turnover	$2.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.68%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	12.73%
1Y total return	40.99%
200-day SMA	34.35
3Y total return	120.68%
50-day SMA	28.81
50-day SMA vs 200-day SMA	50under200
5Y total return	-22.96%
All Time High	1,147.5
All Time High Change	-97.73%
All Time High Date	2001-01-03
All Time Low	6.4
All Time Low Change	306.88%
All Time Low Date	2022-06-13
ATR	1.42
Beta	1.2
Beta1y	1.96
Beta2y	1.94
Ch YTD	-39.2
High	26.96
High52	52.24
High52 Date	2025-11-28
High52ch	-50.15%
Low	26
Low52	16.88
Low52 Date	2025-05-08
Low52ch	54.27%
Ma50ch	-9.62%
Premarket Change Percent	0.61
Premarket Price	$26.4
Premarket Volume	984
Price vs 200-day SMA	-24.19%
RSI	31.72
RSI Monthly	50.17
RSI Weekly	39.61
Sharpe ratio	0.77x
Sortino ratio	1.41
Total Return	-7.68%
Tr YTD	-39.2
Tr15y	-67.49%
Tr1m	-9.36%
Tr1w	-11.43%
Tr3m	-23.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	1
Analyst Price Target Top	$38
Analyst Ratings	Strong Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$0.85
Earnings EPS Estimate Growth	34.92
Earnings Revenue Estimate	61,968,656x
Earnings Revenue Estimate Growth	16.26x
Operating Income	$124.6M
Operating Income Growth	183.6
Operating Income Growth Q	-6.95
Operating margin	41.56
Price target	$51.5
Price Target Change	$97.77
Price Target Change Top	$45.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	17,227,881%
Float Percent	93.11%
Net Borrowing	-15,000,000
Shares Insiders	1.65%
Shares Institutions	87.9%
Shares Out	18,502,080
Shares Qo Q	-0.55%
Shares Yo Y	7.68%
Short Float	23.93%
Short Ratio	12.6
Short Shares	22.28

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$66.4M
Average Volume	354,765.25x
Bv Per Share	21.64
Ch10y	12.73
Ch15y	-67.49
Ch1m	-9.36
Ch1w	-11.43
Ch1y	40.99
Ch20y	-75.43
Ch3m	-23.75
Ch3y	120.7
Ch5y	-22.96
Ch6m	-26
Change	-0.76%
Change From Open	-0.76
Close	26.24
Days Gap	0
Depreciation Amortization	2,408,000
Dollar Volume	7,795,438.6
Earnings Date	2026-05-05
Earnings Time	amc
EBIT	$124.6M
EBITDA	$127M
EPS	$18.95
F Score	6
FCF	$79.3M
FCF EV Yield	20.82x
FCF Per Share	$4.28
Financing CF	-10,802,000
Fiscal Year End	December
Founded	1,996
Graham Number	96.05247
Graham Upside	268.9
Income Tax	$-242.3M
Investing CF	-89,788,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2024-06-27
Last Split Type	Reverse
Last10k Filing Date	2026-03-03
Ma150	34.71
Ma150ch	-24.97%
Ma20	29.95
Ma20ch	-13.06%
Net CF	-21,317,000
Next Earnings Date	2026-08-04
Open	26.24
Optionable	Yes
P FCF Ratio	6.08
P OCF Ratio	6.08
Position In Range	4.17
Post Close	26.04
Postmarket Change Percent	-0.15
Postmarket Price	$26
Ppne	785,000
Pre Close	26.24
Price Date	2026-05-08
Price EBITDA	$3.79
Ptbv Ratio	1.28
Relative Volume	0.84x
Revenue	299,767,000x
SBC By Revenue	4.28x
Share Based Comp	12,843,000
Tax By Revenue	-80.82x
Tr20y	-75.43%
Tr6m	-26%
Us State	California
Volume	299,364
Z Score	2.05

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does RIGL pay a dividend?

Capital-return profile for this ticker.

Performance

RIGL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns RIGL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+87.9%

Float: +93.1% of shares outstanding

Insider ownership

+1.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

RIGL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.7

Neutral momentum band

Price vs 200-day MA

-24.2%

50/200-day relationship not available

Beta (5Y)

1.20

More volatile than the market

Sharpe ratio

0.77

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About RIGL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current RIGL stock rating?

Rigel Pharmaceuticals, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full RIGL analysis?

The full report lives at /stocks/RIGL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for RIGL?

The latest report frames RIGL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the RIGL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.